Latham advises OncoMed in drug development deal
Redwood City-based cancer drug developer OncoMed Pharmaceuticals Inc. relied on counsel from Latham & Watkins LLP in a development alliance struck with Celgene Corp., a cancer drugmaker headquartered in Summit, N.J.
Dechert LLP advised Celgene in the deal, announced Tuesday.
Under terms of the collaborative deal, the two companies will w...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In